Medical Futurist March, 2018
ECG wearable manufacturing Alivecor’s Kardiaband was able to detect atrial fibrillation with very high sensitivity according to the latest study of the Cleveland Clinic published early March. When a physician actually helped examine the data, sensitivity reached 99 percent. A second study, conducted by the Mayo Clinic, showed that the ECG device, when paired with new artificial intelligence technology, is able to detect high potassium levels in blood non-invasively, which could signal diabetes or heart failure.
Doctor and digital health tech: the best combination
AliveCor’s KardiaBand is a novel technology that enables patients to record a rhythm strip using an Apple smartwatch. It is basically a sensor able to detect abnormal heart rhythm and atrial fibrillation (AFib); which sends all...